People: SurModics Inc (SRDX.O)

Summary

Name	Age	Since	Current Position
Robert Buhrmaster	65	2009	Independent Chairman of the Board
Gary Maharaj	49	2010	President, Chief Executive Officer, Director
Andy LaFrence	49	2013	Chief Financial Officer, Vice President
Bryan Phillips	41	2011	Senior Vice President - Legal and Human Resources, General Counsel & Secretary
Charles Olson	48	2010	Senior Vice President & General Manager - Medical Device
Joseph Stich	47	2011	Vice President - Business Operations, General Manager - In-Vitro Diagnostics
Timothy Arens	45	2013	Vice President - Corporate Development and Strategy
Jose Bedoya	56	2002	Independent Director
John Benson	68	2003	Independent Director
Mary Brainerd	58	2009	Independent Director
David Dantzker	69	2011	Independent Director
Gerald Fischer	69	2002	Independent Director
Susan Knight	58	2008	Independent Director
Scott Ward	53	2010	Independent Director

» Insider Trading

Biographies

Name	Description
Robert Buhrmaster	Mr. Robert C. Buhrmaster is the Independent Chairman of the Board of Surmodics Inc. He has been a director of the Company since 2008. Mr. Buhrmaster has been a private investor since 2004. Prior to that, he served as the President and Chief Executive Officer of Jostens, Inc., from 1994 to 2004 and as Chairman from 1998 to 2004. Prior to joining Jostens, Mr. Buhrmaster spent 18 years at Corning, Inc., serving in various roles, including senior vice president and general manager of several businesses, corporate controller and director of strategic planning. Mr. Buhrmaster is also a director of The Toro Company and Caraustar Industries, Inc.
Gary Maharaj	Mr. Gary R. Maharaj is President, Chief Executive Officer, Director of SurModics Inc. He has served as a director and Company's President and Chief Executive Officer since December 2010. Prior to joining SurModics, Mr. Maharaj served as President and Chief Executive Officer of Arizant Inc., a provider of patient temperature management systems in hospital operating rooms, from 2006 to 2010. Previously, Mr. Maharaj served in several senior level management positions for Augustine Medical, Inc. (predecessor to Arizant Inc.) from 1996 to 2006, including Vice President of Marketing, and Vice President of Research and Development. During his 24 years in the medical device industry, Mr. Maharaj has also served in various management and research positions for the orthopedic implant and rehabilitation divisions of Smith & Nephew, PLC. Mr. Maharaj holds an M.B.A. from the University of Minnesota’s Carlson School of Management, an M.S. in biomedical engineering from the University of Texas at Arlington and the University of Texas Southwestern Medical Center at Dallas, and a B.Sc. in Physics from the University of the West Indies. Mr. Maharaj holds over 20 patents, all in the medical device field.
Andy LaFrence	Mr. Andy LaFrence has been appointed as the Chief Financial Officer, Vice President of SurModics, Inc. effective on February 12, 2013. He is a certified public accountant and has over 25 years of finance and management experience. Prior to joining SurModics, he served as Chief Financial Officer of CNS Therapeutics, Inc., since January 2011. He also served as the interim Chief Financial Officer of International Green Power LLC from 2010 to 2011. Prior to that, Mr. LaFrence was an accountant at KPMG LLP, including having served as an audit partner from 1996 to 2010. While at KPMG, Mr. LaFrence focused on supporting public and private, high-growth medical technology, pharmaceutical and biotechnology companies. Mr. LaFrence holds a B.S. in Accounting with a minor in Business Administration from Illinois State University.
Bryan Phillips	Mr. Bryan K. Phillips is Senior Vice President - Legal and Human Resources, General Counsel & Secretary of SurModics Inc. Mr. Phillips joined the Company in July 2005 as Patent Counsel and Assistant General Counsel. In January 2006, Mr. Phillips was appointed Corporate Secretary, and he was promoted to Deputy General Counsel in October 2007. He was promoted to Vice President, General Counsel and Corporate Secretary in September 2008 and was promoted to Senior Vice President in October 2010. In August 2011, he became Senior Vice President, Legal and Human Resources, General Counsel and Secretary. Prior to joining SurModics, from 2001 to 2005, Mr. Phillips served as patent counsel at Guidant Corporation’s Cardiac Rhythm Management Group where he was responsible for developing and implementing intellectual property strategies and also for supporting the company’s business development function. He practiced law at the Minneapolis-based law firm of Merchant & Gould P.C. Mr. Phillips received a B.S. degree in Mechanical Engineering from the University of Kansas in 1993 and a law degree from the University of Minnesota Law School in 1999. He is admitted to the Minnesota bar and is registered to practice before the U.S. Patent and Trademark Office.
Charles Olson	Mr. Charles W. Olson is Senior Vice President & General Manager - Medical Device of SurModics Inc. Mr. Olson joined the Company in July 2001 as Market Development Manager, was promoted in December 2002 to Director, Business Development, named General Manager of the Hydrophilic Technologies business unit in April 2004, and promoted to Vice President and General Manager, Hydrophilic Technologies in October 2004. In April 2005, the position of Vice President, Sales was added to his responsibilities. In November 2008, Mr. Olson was named Vice President of Cardiovascular business unit, in March 2010 he was named Senior Vice President, Business Development and Marketing, and in October 2010, he was named Senior Vice President and General Manager, Medical Device. Prior to joining SurModics, Mr. Olson was employed as General Manager at Minnesota Extrusion from 1998 to 2001 and at Lake Region Manufacturing in project management and technical sales from 1993 to 1998. Mr. Olson received a B.S. degree in Marketing from Winona State University in 1987.
Joseph Stich	Mr. Joseph J. Stich is Vice President - Business Operations, General Manager - In-Vitro Diagnostics of SurModics Inc. He joined the Company in March 2010 as Vice President of Marketing, Corporate Development and Strategy. In August 2011, he became Vice President, Business Operations and General Manager, In Vitro Diagnostics. Before joining SurModics, Mr. Stich was Vice President of Corporate Development for Abraxis BioScience, LLC, a biotechnology company focused on oncology therapeutics, from 2009 to 2010. Prior to joining Abraxis, he was a Vice President for MGI Pharma, Inc., a biopharmaceutical company, from 2005 to 2009. Mr. Stich’s prior experience also includes serving as President/COO of Pharmaceutical Corp. of America (a subsidiary of Publicis Healthcare Specialty Group), and positions of increasing responsibility in sales and marketing at Sanofi-Aventis Pharmaceuticals. He received a B.B.A. degree from the University of Wisconsin — Whitewater in 1988, and an M.B.A. degree from Rockhurst University in Kansas City, Missouri in 1996.
Timothy Arens	Mr. Timothy J. Arens has been appointed as the Vice President - Corporate Development and Strategy of SurModics Inc. effective February 12, 2013. Mr. Arens joined the Company in February 2007 as Director, Business Development and became Senior Director of Financial Planning and Analysis and General Manager, In Vitro Diagnostics in October 2010. He was promoted to his current role as Vice President of Finance and Interim Chief Financial Officer in August 2011. Prior to joining SurModics, Mr. Arens was employed at St. Jude Medical, Inc., a medical technology company, from 2003 to 2007, in positions of increasing responsibility related to business development and strategic planning functions. Mr. Arens received a B.S. degree in Finance from the University of Wisconsin Eau Claire in 1989 and an M.B.A. degree from the University of Minnesota’s Carlson School of Management in 1996.
Jose Bedoya	Mr. Jose H. Bedoya is a Independent Director of SurModics Inc., since 2002. Mr. Bedoya has been a director of the Company since 2002. Mr. Bedoya is President and Chief Executive Officer of Otologics, LLC, a Colorado-based technology company he founded in 1996 to develop implantable devices to assist the severely hearing-impaired. From 1986 to 1996, Mr. Bedoya held a number of positions at Storz Instrument Company, then a division of American Cyanamid and later a division of American Home Products, including Director of Operations, Director of Research and Director of Commercial Development. Prior to that, he served as Vice President of Research and Development for Bausch & Lomb’s surgical division.
John Benson	Mr. John W. Benson is a Independent Director of SurModics Inc. Mr. Benson has been a director of the Company since 2003. Mr. Benson retired from 3M Company in February 2003 where he served in various capacities for 35 years. Prior to his retirement, he served as Executive Vice President, Health Care Markets. Mr. Benson previously served on the Board of Regents at St. Olaf College.
Mary Brainerd	Ms. Mary K. Brainerd is a Independent Director of SurModics Inc., since 2009. Ms. Brainerd has been a director of the Company since 2009. Ms. Brainerd is President and Chief Executive Officer of HealthPartners, Inc., a family of non-profit Minnesota health care organizations headquartered in Minneapolis, Minnesota. She has been with HealthPartners since 1992 and has served as President and Chief Executive Officer since 2002. Prior to joining HealthPartners, Ms. Brainerd held senior level positions with Blue Cross and Blue Shield of Minnesota. Ms. Brainerd also serves on the boards of Minnesota Life/Securian, Minnesota Philanthropy Partners, Greater MSP, Alliance of Community Health Plans, and the Federal Reserve Bank of Minneapolis.
David Dantzker	Dr. David R. Dantzker, M.D., is a Independent Director of SurModics Inc., since 2011. Dr. Dantzker has been a director of the Company since January 2011. Dr. Dantzker has been a Partner at Wheatley Partners L.P., a venture capital fund, since January 2001. He manages Wheatley’s Life Science and Healthcare investments. From 1997 to 2000, Dr. Dantzker was President of North Shore-LIJ Health System, a academic health care system. He also co-founded the North Shore-LIJ Research Institute to direct and coordinate basic science research for the North Shore-LIJ Health System. He is a former Chair of the American Board of Internal Medicine, the physician-certifying board in the United States. Dr. Dantzker served on the board of directors of Datascope Corp. from January 2008 until its sale in January 2009. Dr. Dantzker holds a B.A. in Biology from New York University, and received his M.D. from the State University of New York at Buffalo School of Medicine. Dr. Dantzker sits on the boards of directors of several Wheatley MedTech portfolio companies including Oligomerix, Comprehensive Neurosciences, NovaRay Medical, Inc. and Visionsense, Ltd., a private medical technology company. Dr. Dantzker has also served on the faculty and in leadership positions of four research-oriented medical schools, has authored or co-authored 130 research papers and five textbooks and is an internationally recognized in the area of pulmonary medicine and critical care.
Gerald Fischer	Mr. Gerald B. Fischer is a Independent Director of SurModics Inc. Mr. Fischer has been a director of the Company since 2002. Mr. Fischer is President Emeritus of the University of Minnesota Foundation, a foundation dedicated to advancing the mission of the University of Minnesota, and served as its President and Chief Executive Officer from 1990 through August 2008, and as Vice President, Senior Philanthropy Advisor from August 2008 until December 2010. From 1985 to 1989, Mr. Fischer was with First Bank System, now U.S. Bancorp, serving as Executive Vice President, Chief Financial Officer and Treasurer. Previous to that, he spent 18 years in various finance positions at Ford Motor Company and its affiliates.
Susan Knight	Ms. Susan E. Knight is a Independent Director of SurModics Inc. Since 2001, Ms. Knight has been a director of the Company since 2008. Since 2011, Ms. Knight has served as Senior Vice President and Chief Financial Officer of MTS Systems Corporation, a global supplier of test systems and industrial position sensors, having served as Vice President and Chief Financial Officer at MTS Systems Corporation since 2001. Prior to her position with MTS Systems, from 1977 to 2001, Ms. Knight served in various executive and management positions with Honeywell Inc., last serving as the Chief Financial Officer of the global Home and Building Controls division. Ms. Knight also serves on the board of the Greater Metropolitan Housing Corporation. Ms. Knight also served on the board of Plato Learning, Inc., from 2006 to 2010, where she served on the Audit Committee, including as Chair from 2009 to 2010, and on the Governance and Nominating and a Special Committee from 2009 to 2010.
Scott Ward	Mr. Scott R. Ward is a Independent Director of SurModics Inc. Mr. Ward has been a director of the Company since 2010. Mr. Ward is President of Raymond Holdings, a firm founded in 2011, with activities in venture capital, strategy and transactional advisory services. He has over 30 years of experience in the healthcare industry, including 15 years as an operating business leader. From 1981 until 2010, he served in a variety of positions at Medtronic, Inc., most recently as Senior Vice President and President of the CardioVascular business where he was responsible for all worldwide operations of the CardioVascular business including the Coronary, Peripheral, Endovascular, Structural Heart Disease (SHD) and Revascularization and Surgical Therapies (RST) businesses. Previously, Mr. Ward served as Senior Vice President and President of Medtronic Neurological and Diabetes, with responsibility for the global Neurological, Neurologic Technologies, Diabetes, Gastroenterology and Urology businesses; Vice President and General Manager of the Medtronic Drug Delivery Business; and Director of Medtronic NeuroVentures. Mr. Ward serves on the boards of MAP Pharmaceuticals, Inc. (as Chairman), Creganna-Tactx Medical, Inc., iScience Interventional, Inc., and Respicardia, Inc. He received his Bachelor’s Degree in Genetics and Cell Biology in 1981, and his Masters Degree in Toxicology in 1983, both from the University of Minnesota.

Basic Compensation

Name	Fiscal Year Total
Robert Buhrmaster	--
Gary Maharaj	1,424,690
Andy LaFrence	--
Bryan Phillips	600,651
Charles Olson	573,095
Joseph Stich	629,664
Timothy Arens	530,847
Jose Bedoya	--
John Benson	--
Mary Brainerd	--
David Dantzker	--
Gerald Fischer	--
Susan Knight	--
Scott Ward	--

As Of 29 Sep 2012

Options Compensation

Name	Options	Value
Robert Buhrmaster	0	0
Gary Maharaj	0	0
Andy LaFrence	0	0
Bryan Phillips	0	0
Charles Olson	0	0
Joseph Stich	0	0
Timothy Arens	0	0
Jose Bedoya	0	0
John Benson	0	0
Mary Brainerd	0	0
David Dantzker	0	0
Gerald Fischer	0	0
Susan Knight	0	0
Scott Ward	0	0

Insider Trading

Name	Shares Traded	Price
LEHMAN MARK A	1,693	$26.55
STICH JOSEPH J	1,460	$26.62
OLSON CHARLES W	190	$26.33
OLSON CHARLES W	190	$26.33
LAFRENCE ANDREW D C	5,234	$0.00
KNIGHT SUSAN E	1,472	$0.00
BUHRMASTER ROBERT C	1,472	$0.00
DANTZKER DAVID R	1,472	$0.00
BRAINERD MARY K	1,472	$0.00
FISCHER GERALD B	1,472	$0.00
WARD SCOTT RAYMOND	1,472	$0.00
BEDOYA JOSE H	1,472	$0.00
BENSON JOHN W	1,472	$0.00
STARBOARD VALUE L P	15,425	$17.63
STARBOARD VALUE L P	46,275	$17.63
STARBOARD VALUE L P	4,625	$17.58
STARBOARD VALUE L P	13,875	$17.58
STARBOARD VALUE L P	8,315	$17.61
STARBOARD VALUE L P	75	$17.58
STARBOARD VALUE L P	24,945	$17.61
STARBOARD VALUE L P	25	$17.58
STARBOARD VALUE L P	2,750	$17.77
STARBOARD VALUE L P	8,250	$17.77
STARBOARD VALUE L P	42,500	$17.77
STARBOARD VALUE L P	127,500	$17.77

» Full list on Insider Trading

People: SurModics Inc (SRDX.O)

Related Topics:

Summary

Biographies

Basic Compensation

Options Compensation

Related Topics: